Table 4.
The proportion of the patients with potential inappropriate prescribing at baseline, 6, and 9 months
| Intervention | Control | % point difference (95% CI) | ICCa | |
|---|---|---|---|---|
| Potentially inappropriate prescribing (PIP; STOPP and START combined) | ||||
| Baseline n (%) | n = 31 27 (87.1) | n = 25 20 (80.0) | ||
| 6 months n (%) | n = 24 21 (87.5) | n = 25 20 (80.0) | 7.5 (−13.0, 28.0) | 0.0889 |
| 9 months n (%) | n = 24 21 (87.5) | n = 23 20 (87.0) | 0.5 (−18.6, 19.6) | 0.0000 |
| Potentially inappropriate medications (PIMs; STOPP) | ||||
| Baseline n (%) | n = 31 21 (67.7) | n = 25 14 (56.0) | ||
| 6 months n (%) | n = 24 14 (58.3) | n = 25 15 (60.0) | −1.7 (−29.2, 25.9) | 0.0000 |
| 9 months n (%) | n = 24 16 (66.7) | n = 23 15 (65.2) | 1.5 (−25.7, 28.6) | 0.0000 |
| Potential prescribing omissions (PPOs; START) | ||||
| Baseline n (%) | n = 31 20 (64.5) | n = 25 16 (64.0) | ||
| 6 months n (%) | n = 24 17 (70.8) | n = 25 14 (56.0) | 14.8 (−11.8, 41.5) | 0.1395 |
| 9 months n (%) | n = 24 17 (70.8) | n = 23 13 (56.5) | 14.3 (−12.9, 41.5) | 0.0952 |
CI confidence intervals, ICC intraclass correlation coefficient. No. (%) presented for patients with at least one instance of PIP, PIMs or PPOs
aICCs from mixed-effects models with site as a random effect